Tag: Covishield

Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield

The Drugs Controller General of India (DCGI) on June 4 approved Corbevax as a precaution dose for those aged 18 and above.

  • Wednesday, 10 August 2022
Odisha Health & Family Welfare Director Bijay Panigrahi
14% inoculated with COVID precautionary dose till now in Odisha: Top health official

Raising concerns on slow pace of vaccination in the State, Panigrahi said the government is committed to complete the vaccination drive in the stipulated time period.

  • Monday, 08 August 2022
A man receives a dose of COVID-19 vaccine at Paulista Avenue in Sao Paulo, Brazil on July 25, 2021.
Covishield Vaccine Prices Slashed For Private Hospitals

Serum Institute of India CEO Adar Poonawalla said that SII has decided to revise the price of Covishield vaccine for private hospitals after discussions with the Central government.

  • Saturday, 09 April 2022
2nd Covishield Dose Now Allowed Between 8-16 Weeks After First Jab: NTAGI 

The recommendation for Covishield is yet to be implemented in the national COVID-19 vaccination programme.

  • Sunday, 20 March 2022
Omicron Wave: USA Vs India Vaccination Chart
Covaxin, Covishield Shoots Down Omicron Wave In India, USA Waits For Omicron-Specific Vaccine

With cases remaining on the higher side, both in hospitalisation and mortalities, USA will soon launch Omicron-specific vaccine in March

  • Monday, 21 February 2022
Covishield, Covaxin
Regular Market Approval Granted For Covishield, Covaxin For Use In Adult Population

The DCGI approval came after the SEC on COVID-19 of the CDSCO on January 19 recommended granting regular market approval to the SII's Covishield and Bharat Biotech's Covaxin for use in adult population subject to certain conditions.

  • Thursday, 27 January 2022
Covid vaccine
Covishield, Covaxin Cleared For Regular Market Approval

Hyderabad-based Bharat Biotech had submitted complete information on chemistry, manufacturing, and controls, along with the pre-clinical and clinical data while seeking regular market authorisation for Covaxin.

  • Thursday, 20 January 2022
COVID Vaccine
Total of 158.74 Cr COVID-19 Vaccine Doses Administered; Over 3.7 Cr In 15-18 Age Group Get First Dose

The cumulative COVID-19 vaccine doses administered in the country have reached 158.74 crore so far, the Union Health Ministry said on Tuesday.

  • Tuesday, 18 January 2022
Omicron And Vaccines
Will Booster Dose Give Protection From Omicron: 3.4% Of Vaccinated Positives In India Took 3-doses

Vaccine-induced or Hybrid immunity reduces re-infection chances for 9-10 months only  

  • Thursday, 30 December 2021
Covishield Found 63% Effective In Fully Vaccinated Individuals During 2nd Surge
Covishield Found 63% Effective In Fully Vaccinated Individuals During 2nd Surge

The study provides comprehensive data on the real-world vaccine effectiveness and immunological response to vaccination which should help guide policy. The study thus implies that the vaccines continued to be effective in protecting against severe disease and death regardless of the variants.

  • Tuesday, 30 November 2021
Serum Institute Resumes Export Of Covishield To COVAX
Serum Institute Resumes Export Of Covishield To COVAX

According to the source, the Union government has allowed the commercial export of both vaccines - Covishield and Covaxin - in view of sufficient stock of the vaccines available with the states and Union Territories, and also with the manufacturers.

  • Friday, 26 November 2021
COVID Vaccine
Nepal, India to recognise Covid vax certification

An MoU was signed to recognise Covid-19 vaccine certification by India's Ambassador to Nepal Vinay Mohan Kwatra and the Himalayan nation's Health Secretary on Tuesday.

  • Tuesday, 23 November 2021
110 Countries Recognise India's Covishield, Covaxin: Source
110 Countries Recognise India's Covishield, Covaxin: Source

Of eight WHO-approved vaccines against Covid-19 in emergency use listing, two vaccines -- Covaxin and Covishield -- are from India.

  • Friday, 19 November 2021
UK To Add India's Covaxin To Approved List From November 22

Covishield, the India-manufactured Oxford-AstraZeneca COVID-19 vaccine, was added to the UK's approved list last month.

  • Tuesday, 09 November 2021
After Australia, 5 More Countries Recognise India's Covaxin

Five more countries on Monday recognised India's vaccine certificate, after Australia recognised Bharat Biotech's Covaxin for allowing entry of travellers who had received the vaccine

  • Monday, 01 November 2021